Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
ACS Pharmacology & Translational Science|December 19, 2024
Developing MYC Degraders Bearing the Von Hippel-Lindau Ligand to Target the "Undruggable" MYCChristos Siokatas, Alexandra Lampropoulou, Alexandra Smina, et al.Journal of Medicinal Chemistry|February 13, 2025
BRF110, an Orally Active Nurr1-RXRα-Selective Rexinoid, Enhances BDNF Expression without Elevating TriglyceridesXenophon Asvos, Mohamed A El Mubarak, Theodoros Karampelas, et al.Bioconjugate Chemistry|March 26, 2014
GnRH-Gemcitabine conjugates for the treatment of androgen-independent prostate cancer: pharmacokinetic enhancements combined with targeted drug deliveryTheodoros Karampelas, Orestis Argyros, Nisar Sayyad, et al.Cardiovascular and Interventional Radiology|November 23, 2013
Chemoembolization of hepatocellular carcinoma with HepaSphere 30-60 μm. Safety and efficacy studyKaterina Malagari, Maria Pomoni, Hippokratis Moschouris, et al.Proceedings of the National Academy of Sciences of the United States of America|March 29, 2017
Nurr1:RXRα heterodimer activation as monotherapy for Parkinson's diseaseAthanasios D Spathis, Xenophon Asvos, Despina Ziavra, et al.Cardiovascular and Interventional Radiology|July 10, 2016
Pharmacokinetics, Safety, and Efficacy of Chemoembolization with Doxorubicin-Loaded Tightly Calibrated Small Microspheres in Patients with Hepatocellular CarcinomaKaterina Malagari, Theodoros Kiakidis, Maria Pomoni, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|June 28, 2024
A Novel Fluorescent Gemcitabine Prodrug That Follows a Nucleoside Transporter-Independent Internalization and Bears Enhanced Therapeutic Efficacy With Respect to GemcitabineEirinaios Ι Vrettos, Stavroula G Kyrkou, Vasiliki Zoi, et al.Pageof 2